首页> 外文学位 >Computation Approach to Studying the Pharmacogenetics of Transporters.
【24h】

Computation Approach to Studying the Pharmacogenetics of Transporters.

机译:研究转运蛋白药理学的计算方法。

获取原文
获取原文并翻译 | 示例

摘要

Precision medicine is quickly rising as an influential field of clinical practice and investigation, with new discoveries being published and recent governmental interest. A major area of research for precision medicine is pharmacogenomics, or how genetic factors influence both therapeutic and adverse drug response. Transporters are an important class of proteins in pharmacogenomics research, as they control how pharmaceuticals enter, circulate, distribute and exit the body. As such, this thesis has focused on research related to the pharmacogenetic effects of transporters using computational methods.;An online database was created for researchers to easily access information on transporters. This has become a regularly used tool for the academic, industrial and regulatory research communities. A genome-wide association study (GWAS) was conducted examining selective serotonin reuptake inhibitors, SSRIs, which target the transporter SLC6A4, and the genetic determinants of their therapeutic and adverse drug response. Suggestive associations for therapeutic response were detected for genetic variants in TENM4 and SNTG2, and a variant in CLEC12A was associated at genome-wide significance levels with sexual dysfunction, an adverse effect of SSRIs. A GWAS of baseline serum uric acid levels, which is known to strongly associate with genetic variants in transporters, in a multi-ethnic cohort was also conducted. An analysis in Asians revealed little association with the transporter SLC2A9, a difference when compared to any other ethnicity or even previous Asian studies. A subsequent genome-wide association analysis of the pharmacogenomics of allopurinol, the main treatment for hyperuricemia, revealed a novel association with the transporter ABCG2, which had not been reported to be play a role in the absorption, disposition, or response to allopurinol. Subsequent experiments proved that ABCG2 transports allopurinol and its active metabolite oxypurinol. Together, this dissertation research has expanded our knowledge of the pharmacogenomics of transporters and transporter related drugs.
机译:精密医学作为临床实践和研究的有影响力的领域正在迅速崛起,新的发现正在被发表并且最近受到了政府的关注。精密医学的主要研究领域是药物基因组学,即遗传因素如何影响治疗和药物不良反应。转运蛋白是药物基因组学研究中重要的一类蛋白质,因为它们控制着药物进入,循环,分布和离开人体的方式。因此,本论文着重于利用计算方法研究与转运蛋白的药理作用有关的研究。;建立了一个在线数据库,供研究人员轻松获取有关转运蛋白的信息。这已成为学术,工业和法规研究社区的常用工具。进行了全基因组关联研究(GWAS),研究了针对转运蛋白SLC6A4的选择性5-羟色胺再摄取抑制剂SSRI,及其治疗和不良药物反应的遗传决定因素。在TENM4和SNTG2的遗传变异中发现了治疗反应的暗示关联,而CLEC12A的变异在全基因组显着水平与性功能障碍相关,这是SSRI的不良反应。还进行了多种族队列中的基线血清尿酸水平的GWAS,已知它与转运蛋白的遗传变异密切相关。亚洲人的一项分析显示与转运蛋白SLC2A9几乎没有关联,与任何其他种族或什至以前的亚洲研究相比都没有区别。随后对高尿酸血症的主要治疗药物别嘌呤醇的药物基因组学进行全基因组关联分析,发现与转运蛋白ABCG2有新的关联,尚未报道它与别嘌呤醇的吸收,处置或反应有关。随后的实验证明ABCG2转运别嘌呤醇及其活性代谢产物氧嘌呤醇。总之,本论文的研究扩展了我们对转运蛋白和转运蛋白相关药物的药物基因组学的认识。

著录项

  • 作者

    Wen, Christopher.;

  • 作者单位

    University of California, San Francisco.;

  • 授予单位 University of California, San Francisco.;
  • 学科 Genetics.;Pharmaceutical sciences.;Pharmacology.
  • 学位 Ph.D.
  • 年度 2015
  • 页码 116 p.
  • 总页数 116
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号